We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
-10.36%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$221M
AUM Growth
-$52.5M
Cap. Flow
-$18.4M
Cap. Flow %
-8.32%
Top 10 Hldgs %
57.29%
Holding
108
New
13
Increased
54
Reduced
20
Closed
16
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICVT icon
51
iShares Convertible Bond ETF
ICVT
$7.35B
$497K 0.22%
7,170
+651
+10% +$48.8K
MINT icon
52
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$488K 0.22%
4,928
+86
+2% +$8.57K
EXC icon
53
Exelon
EXC
$47B
$470K 0.21%
+10,360
New +$487K
CNP icon
54
CenterPoint Energy
CNP
$26.8B
$460K 0.21%
+15,537
New +$478K
RPHS
55
DELISTED
Regents Park Hedged Market Strategy ETF
RPHS
$460K 0.21%
+51,985
New +$481K
MCK icon
56
McKesson
MCK
$101B
$441K 0.2%
+1,353
New +$433K
AVGO icon
57
Broadcom
AVGO
$2.04T
$423K 0.19%
+8,710
New +$489K
DVN icon
58
Devon Energy
DVN
$47.3B
$414K 0.19%
7,505
-220
-3% -$14.4K
MOS icon
59
The Mosaic Company
MOS
$7.33B
$397K 0.18%
8,412
-1,088
-11% -$66.6K
MPC icon
60
Marathon Petroleum
MPC
$83.7B
$388K 0.18%
4,725
-3,042
-39% -$284K
MRK icon
61
Merck
MRK
$318B
$345K 0.16%
3,780
+540
+17% +$47.9K
VRTX icon
62
Vertex Pharmaceuticals
VRTX
$126B
$338K 0.15%
1,200
+172
+17% +$46K
JPST icon
63
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$299K 0.14%
5,960
+159
+3% +$7.98K
ABBV icon
64
AbbVie
ABBV
$435B
$289K 0.13%
1,888
-1,123
-37% -$172K
AAPL icon
65
Apple
AAPL
$4.57T
$273K 0.12%
1,994
+22
+1% +$3.33K
BNTX icon
66
BioNTech
BNTX
$23.5B
$262K 0.12%
1,760
+252
+17% +$38.5K
REGN icon
67
Regeneron Pharmaceuticals
REGN
$80.8B
$261K 0.12%
441
+64
+17% +$41.6K
MRNA icon
68
Moderna
MRNA
$23.6B
$244K 0.11%
1,710
+252
+17% +$36K
FVD icon
69
First Trust Value Line Dividend Fund
FVD
$8.41B
$234K 0.11%
6,030
FSK icon
70
FS KKR Capital
FSK
$3.44B
$223K 0.1%
11,501
RAYC
71
DELISTED
Rayliant Quantamental China Equity ETF
RAYC
$211K 0.1%
9,487
-23,750
-71% -$487K
RDVY icon
72
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$205K 0.09%
5,000
RCUS icon
73
Arcus Biosciences
RCUS
$3.64B
$204K 0.09%
8,041
FRA icon
74
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
$202K 0.09%
17,696
+282
+2% +$3.38K
LH icon
75
Labcorp
LH
$25.9B
$196K 0.09%
972
+212
+28% +$45.2K

Similar funds

Anfield Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Anfield Capital Management held 108 positions worth $221M, down 19% from $273M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Anfield Capital Management withdrew a net $18.4M in Q2 2022, closing 16 positions and reducing 20 holdings. Its most notable exit was Anfield Universal Fixed Income ETF, an estimated $3.88M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 2% of assets, up from 1.6% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Anfield Capital Management opened a new position in State Street Consumer Staples Select Sector SPDR ETF worth $18.8M.

  • Anfield Capital Management's largest Q2 2022 buy was State Street Consumer Staples Select Sector SPDR ETF: 259,940 shares worth $18.8M.
  • Anfield Capital Management added most to State Street Health Care Select Sector SPDR ETF in Q2 2022, an estimated $7.33M increase.
  • Anfield Capital Management's biggest Q2 2022 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $22.4M.
  • Anfield Capital Management fully exited Anfield Universal Fixed Income ETF in Q2 2022, selling an estimated $3.88M.
  • Anfield Capital Management's ten largest holdings make up 57% of its $221M portfolio in Q2 2022.
  • Anfield Capital Management opened 13 new positions and closed 16 in Q2 2022.
  • Anfield Capital Management's portfolio value fell 19% quarter-over-quarter to $221M.

Based on Anfield Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.